These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 2213395

  • 1. Treatment of Kawasaki syndrome: a comparison of two dosage regimens of intravenously administered immune globulin.
    Barron KS, Murphy DJ, Silverman ED, Ruttenberg HD, Wright GB, Franklin W, Goldberg SJ, Higashino SM, Cox DG, Lee M.
    J Pediatr; 1990 Oct; 117(4):638-44. PubMed ID: 2213395
    [Abstract] [Full Text] [Related]

  • 2. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.
    Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP.
    N Engl J Med; 1991 Jun 06; 324(23):1633-9. PubMed ID: 1709446
    [Abstract] [Full Text] [Related]

  • 3. High-dose intravenous gamma-globulin therapy in Kawasaki disease.
    Hwang BT, Lin CY, Hsieh KS, Tsuei DH, Meng CC.
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1989 Jun 06; 30(1):15-22. PubMed ID: 2484055
    [Abstract] [Full Text] [Related]

  • 4. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
    Wooditch AC, Aronoff SC.
    Pediatrics; 2005 Oct 06; 116(4):989-95. PubMed ID: 16199713
    [Abstract] [Full Text] [Related]

  • 5. [Study on coronary artery lesions in patients with Kawasaki disease: recent 9 years' experience].
    Wu JR, Hwang KP, Tu JG, Dai ZK, Huang TY.
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Jan 06; 9(1):27-38. PubMed ID: 7682261
    [Abstract] [Full Text] [Related]

  • 6. Prevention of giant coronary artery aneurysms in Kawasaki disease by intravenous gamma globulin therapy.
    Rowley AH, Duffy CE, Shulman ST.
    J Pediatr; 1988 Aug 06; 113(2):290-4. PubMed ID: 2456378
    [Abstract] [Full Text] [Related]

  • 7. The treatment of Kawasaki syndrome with intravenous gamma globulin.
    Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP.
    N Engl J Med; 1986 Aug 07; 315(6):341-7. PubMed ID: 2426590
    [Abstract] [Full Text] [Related]

  • 8. Economic evaluation of intravenous immune globulin therapy for Kawasaki syndrome.
    Klassen TP, Rowe PC, Gafni A.
    J Pediatr; 1993 Apr 07; 122(4):538-42. PubMed ID: 8463897
    [Abstract] [Full Text] [Related]

  • 9. Factors associated with development of coronary artery aneurysms after Kawasaki disease are similar for those treated promptly and those with delayed or no treatment.
    Downie ML, Manlhiot C, Collins TH, Chahal N, Yeung RSM, McCrindle BW.
    Int J Cardiol; 2017 Jun 01; 236():157-161. PubMed ID: 28089146
    [Abstract] [Full Text] [Related]

  • 10. Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease.
    Furukawa S, Matsubara T, Umezawa Y, Motohashi T, Ino T, Yabuta K.
    Eur J Pediatr; 1994 Sep 01; 153(9):663-7. PubMed ID: 7957426
    [Abstract] [Full Text] [Related]

  • 11. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
    Arch Dis Child; 2008 Feb 01; 93(2):142-6. PubMed ID: 17962370
    [Abstract] [Full Text] [Related]

  • 12. Multiple giant succular and fusiform right and left coronary artery aneurysms after early and adequate treatment of atypical kawasaki disease with unusual presentation.
    Behjati-Ardakani M, Ferdosian F.
    Acta Med Iran; 2014 Feb 01; 52(6):490-2. PubMed ID: 25130161
    [Abstract] [Full Text] [Related]

  • 13. Intravenous gamma-globulin for Kawasaki disease.
    Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T.
    Acta Paediatr Jpn; 1991 Dec 01; 33(6):799-804. PubMed ID: 1801560
    [Abstract] [Full Text] [Related]

  • 14. Correlates of coronary artery aneurysm formation in patients with Kawasaki disease.
    Daniels SR, Specker B, Capannari TE, Schwartz DC, Burke MJ, Kaplan S.
    Am J Dis Child; 1987 Feb 01; 141(2):205-7. PubMed ID: 3812389
    [Abstract] [Full Text] [Related]

  • 15. Intravenous gamma-globulin treatment in Kawasaki disease.
    Harada K.
    Acta Paediatr Jpn; 1991 Dec 01; 33(6):805-10. PubMed ID: 1801561
    [Abstract] [Full Text] [Related]

  • 16. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
    Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, Kanegaye JT, Kovalchin JP, Printz BF, Ramilo O, Burns JC.
    Lancet; 2014 May 17; 383(9930):1731-8. PubMed ID: 24572997
    [Abstract] [Full Text] [Related]

  • 17. Kawasaki disease: Medical therapies.
    Newburger JW.
    Congenit Heart Dis; 2017 Sep 17; 12(5):641-643. PubMed ID: 28580631
    [Abstract] [Full Text] [Related]

  • 18. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment.
    Durongpisitkul K, Gururaj VJ, Park JM, Martin CF.
    Pediatrics; 1995 Dec 17; 96(6):1057-61. PubMed ID: 7491221
    [Abstract] [Full Text] [Related]

  • 19. Regression of coronary aneurysms in patients with Kawasaki syndrome.
    Takahashi M, Mason W, Lewis AB.
    Circulation; 1987 Feb 17; 75(2):387-94. PubMed ID: 3802442
    [Abstract] [Full Text] [Related]

  • 20. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
    Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR, Burns JC, Newburger JW.
    J Am Heart Assoc; 2016 Sep 15; 5(9):. PubMed ID: 27633390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.